DEXA Bone Density and Exercise: What Your Scan Results Mean for Your Training

What Your T-Score and Z-Score Actually Tell You

Your DEXA report comes with two numbers: a T-score and a Z-score. They measure the same physical thing (bone mineral density, in g/cm²) but compare you to different populations.

The T-score compares your BMD to a reference database of healthy women aged 20-29. The World Health Organization diagnostic thresholds define a T-score at or above -1.0 as normal, -1.0 to -2.5 as osteopenia, and -2.5 or below as osteoporosis. [1] Fracture risk roughly doubles for every 1-point drop in T-score at the hip. [2]

The Z-score compares you to women your own age and ethnicity. A Z-score below -2.0 is flagged as "below the expected range for age." In premenopausal women and children, ISCD guidelines recommend using the Z-score rather than the T-score for clinical decision-making, because comparing a 30-year-old to a 25-year-old peak-bone-mass reference can mislead. [3]

What "Optimal" Actually Looks Like

There is no single "optimal" number because fracture risk is a continuous gradient. The goal in clinical practice is to keep your T-score above -1.0 at the lumbar spine and total hip. For a woman in her reproductive years, a Z-score above 0.0 (meaning you are denser than average for your age) is a favorable sign. For a postmenopausal woman, The Menopause Society (formerly NAMS) emphasizes that the absolute 10-year fracture probability from the FRAX tool, not the T-score alone, should guide treatment decisions. [4]

Why Women Lose Bone Faster Than Men

Estrogen directly stimulates osteoblast activity and suppresses osteoclast-driven resorption. When estrogen falls at menopause, that brake on resorption lifts. Cauley et al. In the Journal of Bone and Mineral Research documented annual BMD losses of 1.8-2.3% at the lumbar spine during the first three postmenopausal years in untreated women. [5] Men lose bone too, but more slowly and without the abrupt estrogen withdrawal trigger that women experience.

Across the menstrual cycle, estradiol fluctuations also affect bone turnover markers measurably, though the net clinical effect on annual BMD in eumenorrheic women is small. The women at highest short-term risk are those with hypothalamic amenorrhea, premature ovarian insufficiency (POI), or surgical menopause.

How Exercise Changes Your DEXA Score

Exercise is the most evidence-supported non-pharmacological strategy for building and maintaining BMD. The effect is site-specific (bone responds where mechanical load is applied), dose-dependent, and modality-dependent.

Weight-Bearing Impact Exercise

Impact loading, meaning activities where your foot strikes the ground with force above body weight, generates ground reaction forces that travel up the skeleton and stimulate osteogenesis. Walking produces roughly 1.1 times body weight at the hip. Jogging produces 2.5-3.0 times body weight. Jumping can exceed 5 times body weight.

The LIFTMOR randomized controlled trial enrolled 101 postmenopausal women with low bone mass and compared supervised high-intensity resistance and impact training (HiRIT) against a low-intensity exercise program. [6] After eight months, the HiRIT group gained 2.9% at the femoral neck and 2.8% at the lumbar spine. The low-intensity group lost BMD at both sites. These are clinically meaningful differences achieved without pharmacotherapy.

Progressive Resistance Training

Muscle contraction places compressive and tensile forces on the bone at attachment points. The lumbar vertebrae, femoral neck, and distal radius respond most strongly to the exercises that load those sites: squats and deadlifts for the spine and hip, loaded carries for the forearm.

A 2022 meta-analysis in Osteoporosis International pooled 18 RCTs in postmenopausal women and found that progressive resistance training produced a weighted mean difference of +1.03% at the lumbar spine (95% CI 0.53-1.53%) compared with controls. [7] The trials using loads above 75% of one-repetition maximum produced the largest effects, which fits the mechanostat hypothesis: bone remodels to handle the strains it actually encounters.

What Doesn't Move the Needle Much

Swimming and cycling are cardiovascular health workouts but provide minimal skeletal stimulus. Water buoyancy in swimming essentially offloads bone. Cycling, unless combined with standing efforts, keeps ground reaction force near zero. Women who rely exclusively on these modalities for fitness often show average or below-average BMD for age, particularly at the hip. This does not mean avoid swimming, it means add load-bearing work alongside it.

How Long Before DEXA Catches the Change?

DEXA resolution limits and normal biological variability mean that a single DEXA repeated sooner than 12-24 months will rarely show statistically significant change. The least significant change (LSC) at most DXA centers is approximately 2-3% at the lumbar spine. [8] If your training program adds 1% per year at the spine, you need roughly two years of consistent training before your follow-up DEXA will reliably detect the gain above measurement noise.

Tracking bone turnover markers (serum CTX for resorption, serum P1NP for formation) can give you an earlier signal. Both respond to training within 8-12 weeks, well before DEXA shifts.

Bone Density Across Your Reproductive Life

No two DEXA results mean the same thing because life stage changes the entire context of interpretation. Here is a stage-by-stage framework clinicians at WomanRx use when reviewing your scan.

Reproductive Years (Ages 20-40)

You are ideally near or at peak bone mass, which is usually reached between ages 25 and 30. A Z-score below -2.0 in this age group demands investigation before assuming exercise alone will correct it. Causes include: prior or current eating disorders, hypothalamic amenorrhea (including athletic amenorrhea), inflammatory bowel disease, celiac disease, long-term glucocorticoid use, and undiagnosed POI.

Women with PCOS present an interesting picture. Despite often having irregular cycles and androgen excess, many have normal or above-normal BMD because androgens are partially converted to estrogen peripherally and insulin-like growth factor-1 levels tend to be elevated. [9] This does not mean PCOS is protective against osteoporosis long-term, especially in lean women who develop POI.

If you have hypothalamic amenorrhea and are exercising intensely, the Female Athlete Triad coalition and ACOG Practice Bulletin recommend DEXA screening and a structured energy availability assessment. [10] Exercise alone will not restore bone in the setting of low estrogen; the underlying energy deficit must be corrected first.

Trying to Conceive and Fertility Treatment

No DEXA-specific contraindication exists for women trying to conceive. Radiation dose from a standard two-site DEXA (lumbar spine plus hip) is approximately 1-6 microsieverts, well below any threshold of concern. For comparison, a cross-country flight exposes you to roughly 30-40 microsieverts of cosmic radiation.

Women undergoing ovarian stimulation for IVF have transiently elevated estradiol levels, which may temporarily improve bone turnover markers, though this is not studied systematically enough to draw clinical conclusions.

Pregnancy and Postpartum

Pregnancy is a period of temporary, physiologically normal BMD reduction. The fetus draws approximately 30 grams of calcium across the third trimester. Maternal bone resorption rises to meet that demand even when calcium intake is adequate. A 2018 review in Endocrine Reviews documented BMD losses of 3-5% at the lumbar spine during pregnancy. [11] This reverses after delivery and, for non-lactating women, is substantially restored by 6-12 months postpartum.

Lactation extends the BMD dip. Prolactin suppresses ovarian estrogen production, so breastfeeding women are in a temporary hypoestrogen state. Kalkwarf and Specker's landmark study showed lactating women lose 4-7% of lumbar spine BMD over six months of exclusive breastfeeding. [12] The good news: BMD recovery after weaning is well documented and strong in women with adequate nutrition. A postpartum or post-lactation DEXA will artificially underestimate your long-term baseline and should not prompt pharmacotherapy without a repeat scan 6-12 months after full weaning.

Exercise during pregnancy and postpartum is safe and encouraged by ACOG. [13] Resistance training and weight-bearing activity during pregnancy may attenuate (though cannot eliminate) pregnancy-related BMD loss, though data from prospective trials in this specific population are limited.

Perimenopause (Typically Ages 45-55)

This is the highest-risk window for rapid bone loss. The menopausal transition begins, on average, 4 years before the final menstrual period. Bone loss accelerates in the 2 years before and 3 years after the final period. The Study of Women's Health Across the Nation (SWAN) followed over 2,000 women through the menopausal transition and documented mean lumbar spine BMD loss of 2.5% per year in the late perimenopause and first postmenopausal year. [14]

Starting or intensifying resistance training in perimenopause is among the most time-sensitive clinical actions you can take. The LIFTMOR trial (cited above) showed gains are achievable even in women who already have osteopenia. Perimenopausal women who are candidates for menopausal hormone therapy (MHT) should know that estrogen is the only agent proven to prevent postmenopausal bone loss while simultaneously addressing vasomotor symptoms. Bone is a valid co-indication for MHT in women under 60 or within 10 years of menopause, per The Menopause Society 2023 Position Statement. [15]

Post-Menopause (Age 55+)

Bone loss slows relative to the transition years but continues at roughly 0.5-1.0% per year at the hip indefinitely. The USPSTF recommends DEXA screening for all women aged 65 and older, and for younger postmenopausal women whose 10-year fracture risk (via FRAX) equals or exceeds that of a 65-year-old white woman with no additional risk factors. The 2018 USPSTF Recommendation Statement gives this a Grade B recommendation. [16]

Exercise prescription for postmenopausal women should include progressive resistance training 2-3 days per week at loads above 75% of 1-RM where tolerated, plus impact loading such as jogging, stair climbing, or jumping, and balance training to reduce fall risk. The 2019 ACSM Position Stand on Physical Activity and Bone Health recommends exactly this combination. [17]

When Exercise Alone Is Not Enough

Exercise is a first-line tool, not a substitute for pharmacotherapy when fracture risk is high. For postmenopausal women with a T-score at or below -2.5, or a T-score between -1.0 and -2.5 with a 10-year major osteoporotic fracture probability at or above 20% (or hip fracture probability at or above 3%) per FRAX, pharmacological intervention is generally indicated per American Association of Clinical Endocrinology 2020 guidelines. [18]

First-line pharmacotherapy is typically an oral bisphosphonate (alendronate 70 mg weekly or risedronate 35 mg weekly). Denosumab 60 mg subcutaneously every six months is an option for women who cannot tolerate oral bisphosphonates. Anabolic agents (teriparatide, abaloparatide) are reserved for severe disease or bisphosphonate failure. Romosozumab is FDA-approved for women at high fracture risk in postmenopause but carries a boxed warning for cardiovascular events.

None of these drugs are safe in pregnancy. Bisphosphonates incorporate into bone matrix and have a half-life measured in years; they should be avoided preconceptionally if possible and stopped well in advance of a planned pregnancy. A 2019 systematic review in Osteoporosis International found no consistent signal of fetal harm in inadvertent first-trimester exposure to bisphosphonates, but the data are sparse and the standard recommendation remains avoidance. [19] If you are premenopausal with severe bone loss requiring bisphosphonate treatment and you may want to conceive, discuss the timing with both your prescriber and a reproductive endocrinologist.

Denosumab causes rebound bone loss when stopped abruptly. Women who conceive on denosumab (rare, but reported) face difficult clinical decisions. Discontinuation during pregnancy has been followed by severe rebound hypercalcemia and vertebral fractures. This is a clinical situation requiring specialist management, not a simple pause.

Designing a Bone-First Exercise Program: Practical Guidance

A bone-focused training plan has four components. They do not all need to happen on the same day.

Progressive Resistance Training

Train 2-3 days per week with compound lower-body and spine-loading movements: squats, Romanian deadlifts, hip thrusts, and loaded carries. Work toward loads at or above 75% of your estimated 1-RM. The LIFTMOR protocol used 5 sets of 5 repetitions at 80-85% 1-RM with careful supervision, which is a reasonable target for women with osteopenia who have been cleared by their provider. [6]

Impact Loading

Add 50-100 moderate-impact foot strikes per session 3-4 days per week. This can be jogging, skipping, stair climbing at pace, or even structured jumping protocols. The OsteoStrong and BELL studies tested brief, high-magnitude loading devices and showed hip BMD gains of 1.5-4.7% in postmenopausal women. [20] You do not need specialized equipment; a brisk 20-minute run provides an adequate stimulus.

Balance and Fall Prevention

Falls cause fractures. Yoga, tai chi, and single-leg balance exercises reduce fall rates by 20-30% in older women, per a Cochrane review of fall prevention interventions. [21] Balance training belongs in the program even when you feel stable, because proprioceptive decline often precedes any subjective awareness.

Nutrition Anchors

No exercise program works without the raw materials. Calcium intake of 1,000-1,200 mg per day (from food first) and vitamin D levels sufficient to keep serum 25-OH-D above 30 ng/mL are baseline requirements. Adequate total protein (at least 1.2 g/kg body weight per day) supports both muscle and collagen matrix synthesis. If your diet consistently falls short, supplementation is warranted.

Evidence Gaps: What We Don't Yet Know

Women have been under-represented in exercise-and-bone trials. Most landmark RCTs (including LIFTMOR) enrolled postmenopausal women in their 60s. Data for premenopausal women with low bone mass, women with POI, or women during the perimenopausal transition specifically are sparse. The optimal exercise dose, intensity, and modality for women on aromatase inhibitors (used in breast cancer treatment, which causes rapid bone loss) are being studied but no completed large RCT exists yet. What we know about impact loading thresholds comes largely from studies in older women; translating those numbers to a 38-year-old with amenorrhea involves extrapolation. A clinician who tells you otherwise is overstating the evidence.